Showing results (1231-1240 of 3,023) with videos related to
Sort By:
Pageof 303
Current Drug Targets|March 14, 2007
Purine nucleoside phosphorylase: a potential target for the development of drugs to treat T-cell- and apicomplexan parasite-mediated diseasesR G Silva, J E S Nunes, F Canduri, et al.Current Drug Targets|March 14, 2007
Mycobacterial shikimate pathway enzymes as targets for drug designR G Ducati, L A Basso, D S SantosCurrent Drug Targets|March 14, 2007
The inhibition of 5-enolpyruvylshikimate-3-phosphate synthase as a model for development of novel antimicrobialsMaurício Ribeiro Marques, José Henrique Pereira, Jaim S Oliveira, et al.Current Drug Targets|March 14, 2007
Identifying and attaining LDL-C goals: mission accomplished? Next target: new therapeutic options to raise HDL-C levelsVasilios G Athyros, Dimitri P Mikhailidis, Anna I Kakafika, et al.Current Drug Targets|May 17, 2007
Glycine transporter 1 inhibitors and modulation of NMDA receptor-mediated excitatory neurotransmissionCyrille Sur, Gene G KinneyCurrent Drug Targets|August 12, 2008
Diacylglycerol kinases as emerging potential drug targets for a variety of diseasesFumio Sakane, Shin-ichi Imai, Masahiro Kai, et al.Current Drug Targets|August 12, 2008
Molecular targeting of acid ceramidase: implications to cancer therapyYoussef H Zeidan, Russell W Jenkins, John B Korman, et al.Current Drug Targets|August 12, 2008
Ceramide kinase and the ceramide-1-phosphate/cPLA2alpha interaction as a therapeutic targetNadia F Lamour, Charles E ChalfantCurrent Drug Targets|October 16, 2008
Thrombospondin-1 in von Willebrand factor functionArnaud Bonnefoy, Marc F HoylaertsCurrent Drug Targets|October 16, 2008
Enhancing cardiovascular dynamics by inhibition of thrombospondin-1/CD47 signalingJeff S Isenberg, William A Frazier, Murali C Krishna, et al.Pageof 303